Drug export pathway of multidrug exporter AcrB revealed by DARPin inhibitors

Gaby Sennhauser1, Patrick Amstutz, Christophe Briand

  • 1University of Zurich, Zurich, Switzerland.

Plos Biology
|December 30, 2006
PubMed

Insights

The crystal structure of the multidrug exporter AcrB reveals distinct channels within its subunits, suggesting a novel drug export pathway. This finding advances understanding of how Escherichia coli achieves multidrug resistance.

Area of Science:

  • Structural Biology
  • Microbiology
  • Biochemistry

Background:

  • AcrB is a key component of the AcrAB-TolC efflux system in Escherichia coli, conferring resistance to numerous drugs.
  • Understanding the mechanism of AcrB is crucial for combating antimicrobial resistance.

Purpose of the Study:

  • To elucidate the structural basis of the multidrug exporter AcrB's function.
  • To investigate the drug transport pathway and proton motive force utilization.

Main Methods:

  • X-ray crystallography was used to determine the structure of trimeric AcrB.
  • A designed ankyrin-repeat protein (DARPin) inhibitor was used in complex with AcrB.

Main Results:

  • The crystal structure of AcrB in complex with a DARPin inhibitor was resolved at 2.5-A resolution.
  • The three AcrB subunits were observed in distinct conformations, revealing unique channels within each subunit.
  • Evidence suggests remote conformational coupling between channel access, exit, and proton translocation sites.

Conclusions:

  • The multidrug export pathway likely involves channels within individual AcrB subunits, not a central pore.
  • This structural insight provides a deeper understanding of the AcrB-mediated multidrug efflux mechanism.
  • The findings advance knowledge of how proton motive force drives drug export in bacteria.

Related Concept Videos

ABC Transporters: Exporter01:31

ABC Transporters: Exporter

ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
ABC Transporters: Importer01:27

ABC Transporters: Importer

ATP-binding cassette or ABC transporters are a class of ATP-driven pumps that hydrolyze ATP to move solutes across the membrane. They can be grouped into importers and exporters. While exporters are present in all domains of life, importers exist only in bacteria and some plants.
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
Nuclear Export01:42

Nuclear Export

The nucleus restricts several proteins within and allows others to pass. The restricted proteins possess a nuclear retention sequence or NRS, anchoring them to the nuclear lamins and preventing their transport to the cytosol. The non-restricted proteins, after their synthesis, are transported to their site of action, such as the cytosol or other organelles, with the help of nuclear export signals or NES.
NES are of three types- the canonical 10-residue long leucine-rich signal and other...
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...